Tuesday July 14, 2020 17:30

Heathcare Press Release : 25 Jun 2019

Open nursing course to accelerate the safe practice of Peripheral Intravenous Cannula Insertion Heathcare—25 Jun 19

"Peripheral Intravenous Cannula Insertion is a very broad term and not likely to be understood by people outside the medical community. In simple terms, it means the provision of saline, medication or blood products through an intravenous device and

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres(R) Y-90 resin microspheres Heathcare—25 Jun 19

WOBURN, Massachusetts--25 Jun--PRNewswire/InfoQuest

Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced delivery of the 100,000th patient dose of SIR-Spheres(R) Y-90 resin microspheres, a treatment for patients with liver cancer.* More than 1,000 healthcare providers and hospital systems across the globe offer this treatment.

"This milestone would not have been possible without the support of healthcare professionals around the world, along with Sirtex's significant investment in our Interventional Oncology clinical program. We are also very proud to have such dedicated employees who place patients first and are focused on achieving excellence in their effort to improve the quality and longevity of patients' lives," said Kevin Smith, interim CEO of Sirtex. "However, this is the first of many milestones as we continually strive to develop new ways to improve the delivery of SIR-Spheres Y-90 resin microspheres and advance the standard of care."

Since the company's creation, Sirtex has been committed to providing best-in-class training, support and education to the multi-disciplinary teams caring for patients with liver cancer to ensure those who will benefit the most from int